KeyCorp Has Lowered Expectations for Doximity (NASDAQ:DOCS) Stock Price

Doximity (NASDAQ:DOCS) had its target price trimmed by KeyCorp from $70.00 to $65.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has an overweight rating on the stock.

Several other equities analysts have also recently issued reports on the company. Truist Financial boosted their price objective on Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a report on Thursday, November 14th. Raymond James restated an “outperform” rating and issued a $65.00 price objective (up previously from $37.00) on shares of Doximity in a research report on Friday, November 8th. JPMorgan Chase & Co. lifted their target price on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a report on Thursday, November 21st. Barclays increased their price target on shares of Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a report on Monday, November 11th. Finally, Mizuho initiated coverage on Doximity in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $55.00 price target for the company. Thirteen research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Doximity has an average rating of “Hold” and an average target price of $53.00.

Doximity Price Performance

Shares of Doximity stock opened at $54.93 on Wednesday. The stock has a market cap of $10.25 billion, a PE ratio of 63.14, a price-to-earnings-growth ratio of 4.16 and a beta of 1.38. The firm has a fifty day moving average price of $52.62 and a 200 day moving average price of $41.32. Doximity has a 1 year low of $22.96 and a 1 year high of $61.75.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. FMR LLC boosted its stake in Doximity by 30.5% during the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock worth $297,920,000 after buying an additional 1,598,602 shares during the last quarter. William Blair Investment Management LLC boosted its position in shares of Doximity by 15.8% during the 2nd quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock valued at $179,122,000 after acquiring an additional 873,682 shares during the last quarter. Clearbridge Investments LLC grew its holdings in shares of Doximity by 7.1% in the second quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock valued at $163,709,000 after purchasing an additional 387,200 shares during the period. State Street Corp grew its holdings in shares of Doximity by 2.5% in the third quarter. State Street Corp now owns 3,693,982 shares of the company’s stock valued at $160,947,000 after purchasing an additional 88,922 shares during the period. Finally, Geode Capital Management LLC increased its position in Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after purchasing an additional 472,565 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.